Medable Named a Leader Amid Growing eCOA Adoption

PALO ALTO, Calif.--(BUSINESS WIRE)--Sep 17, 2025--

Medable Inc., a leading provider of clinical trial technology, today announced it has been named a Leader in Everest Group’s 2025 "Life Sciences Electronic Clinical Outcome Assessment (eCOA) Products PEAK Matrix® Assessment." Medable was recognized among 19 vendors for its strong performance across three key areas: buyer priorities, innovation, and future focus.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250917914493/en/

Medable was named a Leader for its continued investment in AI and machine learning to enhance platform efficiency, localization, real-time analytics, broad multimodal data capture, and strategic partnerships. Buyers highlighted Medable’s flexible and competitive pricing models. The platform supports multimodal data capture—including web, mobile, and bring-your-own-device—underscoring its technical maturity and adaptability.

The adoption of eCOA software is accelerating as clinical trials increasingly shift toward digital solutions. According to The Business Research Company, the eCOA and eSource market is experiencing significant growth, driven by the demand for improved data accuracy, regulatory compliance, and patient-centric trial designs.

“Medable is proud to be recognized for driving meaningful innovation in clinical research – particularly for this critical, sought-after technology,” said Dr. Michelle Longmire, CEO and co-founder of Medable. “This reflects our continued focus on building technology that simplifies trials, improves data quality, and keeps patients and sites at the center. We're committed to pushing the industry forward and driving toward our 1:1:1 vision.”

With the recent launch of Agent Studio, Medable continues to lead digital transformation in life sciences. Sponsors and CROs can now deploy AI-powered agents to address costly manual bottlenecks in development and close the “white space” of clinical trials, which accounts for 45% of total clinical development timeline.

Learn more about the growth of the eCOA market and the benefits cloud-based eCOA platforms bring to clinical trialshereand about Medable’sAI-powered eCOA here.

About Medable

Medable is on a mission to get effective therapies to people faster. Its digital clinical trials platform enhances speed, scale, and patient access in clinical research, accelerating medicines for thousands of conditions without treatment or cure. Awarded Best Digital Health Solution by the Galien Foundation, Medable’s platform has been deployed in nearly 400 trials in 70 countries and 120 languages, serving more than one million patients globally. Medable is a privately held, venture-backed company headquartered in Palo Alto, California, and was listed for the second year in a row on the Inc. 5000 in 2024.

Life Sciences Electronic Clinical Outcome Assessment (eCOA) Products PEAK Matrix® Assessment 2025 | Medable is positioned as a Leader

BANGKOK (AP) — Myanmar’s parliament on Friday elected Min Aung Hlaing, a general who ousted Aung San Suu Kyi’s civilian government in 2021 and kept an iron grip on power for the past five years, as the country’s new president.

The move marks a nominal return to an elected government but is widely considered to be an effort to keep the army in power after an election organized by the military that opponents and independent observers deemed neither free nor fair.

Min Aung Hlaing was one of three nominees for the president’s post, but was virtually guaranteed the job as lawmakers from military-backed parties and appointed members from the army hold a commanding majority in parliament.

Aung Lin Dwe, speaker of parliament’s combined upper and lower house, announced that Min Aung Hlaing won 429 out of the 584 votes. The two runners-up became vice presidents.

Min Aung Hlaing, who holds the rank of senior general, had earlier relinquished his post of the commander-in-chief because the constitution prohibits the president from simultaneously holding the top military position. A close aide, Gen. Ye Win Oo, took over the powerful job.

The 69-year-old Min Aung Hlaing had been the military chief since 2011. Under a military-imposed constitution, he held major power even before overthrowing Suu Kyi’s government.

Parliament members were elected in three phases in December and January. Major opposition parties, including Suu Kyi’s former ruling National League for Democracy, were either blocked from running or refused to compete under conditions they deemed unfair. Suu Kyi has been held in prison.

Parliament chairman Aung Lin Dwe, center, arrives for a session of Union Parliament in Naypyitaw, Myanmar, Friday, April 3, 2026. (AP Photo/Aung Shine Oo)

FILE - Senior Gen. Min Aung Hlaing, head of Myanmar's military council, inspects officers during a parade to commemorate Myanmar's 78th Armed Forces Day in Naypyitaw, Myanmar, March 27, 2023. (AP Photo/Aung Shine Oo, File)

Myanmar's military representatives and lawmakers arrive to attend a session at Union parliament in Naypyitaw, Myanmar, Friday, April 3, 2026.(AP Photo/Aung Shine Oo)

Myanmar's military representatives arrive for a session at Union parliament in Naypyitaw, Myanmar, Thursday, April 2, 2026. (AP Photo/Aung Shine Oo)

Myanmar's military representatives arrive for a session at Union parliament in Naypyitaw, Myanmar, Friday, April 3, 2026. (AP Photo/Aung Shine Oo)

Parliament chairman Aung Lin Dwe arrives for a session of Union Parliament in Naypyitaw, Myanmar, Friday, April 3, 2026. (AP Photo/Aung Shine Oo)

Parliament chairman Aung Lin Dwe, center, arrives for a session of Union Parliament in Naypyitaw, Myanmar, Friday, April 3, 2026. (AP Photo/Aung Shine Oo)